With a focus on disease-relevant cellular models, iXCells offers a wide range of products and services to the academic, biotech, and pharma communities. Their extensive product lineup includes high-quality primary cells, iPSC-derived cells, and growth media & reagents, among others. The company's mission is to become a globally recognized innovation-oriented biotech enterprise that is trusted and respected by customers and peer researchers.

They are committed to providing innovative drug discovery solutions with a focus on disease-relevant cellular models. They prioritize self-improvement and continuously work towards developing their capabilities and potential. With a network of collaborators and partners, iXCells is dedicated to accelerating the pace of drug discovery in order to contribute to advancements in healthcare